Health Encyclopedia

 

Health Encyclopedia Home



Cancer Drug May Be Helpful for Diabetes, Mouse Study Hints

Cancer Drug May Be Helpful for Diabetes, Mouse Study Hints

SUNDAY, Sept. 15 (HealthDay News) -- The cancer drug Zaltrap (aflibercept) could help treat diabetes, suggest findings from research using mice.

Scientists say they've identified a molecular pathway (a series of interactions among proteins) involved in the development of diabetes, and also found that the drug can regulate this pathway.

Zaltrap is approved in the United States to treat metastatic (spreading) colorectal cancer and the wet form of the eye disease macular degeneration. The drug inhibits the vascular endothelial growth factor (VEGF) pathway, thereby blocking the growth of blood vessels into tumors and starving them of oxygen.

The researchers, from the Stanford University School of Medicine, identified a series of proteins that link VEGF inhibitors and blood glucose levels.

"We were surprised to find that this drug currently used in patients for cancer treatment had beneficial effects on diabetes in laboratory mice and could, potentially, in humans," Dr. Calvin Kuo, a professor of medicine, said in a university news release.

Scientists caution, however, that research with animals often fails to provide similar results in humans.

"Proteins involved in this pathway could be targeted for the development of new diabetes therapies," Amato Giaccia, a professor of cancer biology and director of radiation oncology, said in the news release.

The findings appeared online Sept. 15 in two articles in the journal Nature Medicine.

The researchers said there have been indications that VEGF inhibitors such as Zaltrap could influence blood glucose levels in people, but no human studies have been conducted.

"Anecdotally, there have been reports that diabetic patients who have been prescribed VEGF inhibitors to treat their cancer are better able to control their diabetes," Kuo said.

Three co-authors of Kuo's study are employees at Regeneron Pharmaceuticals, which makes aflibercept.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diabetes.

SOURCE: Stanford University School of Medicine, news release, Sept. 15, 2013

 
Related Items
Wellness Library
  Medical Symptoms You Should Never Ignore
SCC Videos
  Colon Cancer Screening
Content Type 134
  How Lifestyle and Medical History Affect Cancer Risk: Facts for Gay and Bisexual Men
Content Type 167
  Fecal Occult Blood Test
Nutritional Supplement Advisor
  Fiber
  Green Tea Extract
Drug Reference
  Floxuridine
  Bevacizumab
  Irinotecan
  Leucovorin
Daily News Feed
  Family History of Cancer May Raise Risk for Other Types of Tumors
  Experts Call for Redefinition of 'Cancer'
  Mailed Invites May Boost Colon Cancer Screening Rates: Study
  Colon Cancer Linked to Mouth Infection, Gum Disease?
  ER Visits Common After Seniors' Surgery, Study Finds
  First Generic Version of Xeloda Approved
  Colon Cancer Screenings Work, Twin Studies Report
  Smokers Have Higher Complication Risk After Colon Surgery, Study Finds
  Seeing Doctor Regularly May Cut Your Colon Cancer Risk
  Colon Cancer Hits Younger Adults Especially Hard, Study Finds
  Laparoscopic Surgery for Colon Cancer May Benefit Seniors
  Gene May Explain Link Between Meat and Colon Cancer Risk
  Being Web-Savvy Tied to Better Health in Seniors: Study
  Current Colon Cancer Screening Guidelines Might Miss Some Patients
  Too Much Sitting Tied to Higher Risk of Colon Polyps in Men
  1 in 3 Not Meeting Colon Cancer Screening Guidelines: CDC
  Poor Diet May Spur Inflammation-Related Health Problems
  Blacks Less Likely to See Cancer Specialists, Study Finds
  Germs That Inhabit Gut May Affect Colon Cancer Risk
  New Test May Help Predict Survival From Ovarian Cancer
  U.S. Cancer Death Rates Continue to Decline: Report
  80 Percent of Cancer Docs Have Faced Drug Shortages: Survey
  U.S. Cancer Deaths Decline Again: Report
  Post-Surgical Tests Might Help Spot Colon Cancer's Return
  Progress Against Cancer May Be Greater Than Thought
  At-Home Stool Test for Colon Cancer Called Accurate, But Not Foolproof
  'Fat Hormone' Tied to Higher Colon Cancer Risk in Obese Men
  Three Groups Miss Out on Colon Cancer Survival Gains, Study Says
  Ways to Cut Your Colon Cancer Risk
  Colon Cancer Cases Decline for Older Americans
  New Stool Test Shows Promise as Colon Cancer Screen
  Colonoscopy Is Good, Not Perfect
  Slight Drop in Rate of Advanced Cancers, CDC Says
  FDA Advisory Panel Recommends Approval of At-Home Colon Cancer Test
  Certain Colon Cancer Patients Might Benefit From Aspirin, Study Says
  Doctors' Skill at Colonoscopy May Affect Patients' Colon Cancer Risk: Study
  Obesity May Shorten Colon Cancer Survival
  Age a Big Factor in Colon Surgery Complications, Study Finds
  Aspirin's Ability to Prevent Colon Cancer May Depend on Your Genes
  New Colon Polyp Removal Method May Be Easier on Patients
  First-Time Colon Cancer Screening May Be Beneficial for Elderly
  Fish, Exercise May Help Thwart Colon Cancer's Return: Study
  Half a Million Cancers Prevented by Colon Screenings: Study
  Tumor-Targeting Agent Attaches to Cancer Cells: Study
  Study Ties Too Much Sitting to Risks for Certain Cancers
  Popular Crohn's, Colitis Drugs Not Linked to Short-Term Cancer Risk: Study
  New Clues to Why Blacks Fare Worse With Colon Cancer
  Diets High in Dairy Might Boost Colon Cancer Survival, a Bit
  HIV Patients Less Likely to Get Cancer Treatment: Study